Bank of America assumed coverage on shares of AlloVir (NASDAQ:ALVR – Free Report) in a report published on Friday, MarketBeat.com reports. The brokerage issued a buy rating and a $17.00 target price on the stock. Other equities analysts have also issued reports about the company. SVB Securities upped their target price on AlloVir from $16.00 […]